| Metric | FY2024 | FY2023 | FY2022 | FY2021 | FY2020 |
|---|---|---|---|---|---|
| Net revenue | $11.7M-64.8% | $33.2M-27.6% | $45.9M+30.1% | $35.3M+12.5% | $31.3M |
| Cost of revenue (exclusive of depreciation and amortization shown separately below) | $8.8M-66.7% | $26.4M-23.6% | $34.6M+39.8% | $24.7M+8.8% | $22.8M |
| Bad debt expense | $170K | — | — | — | — |
| Research and development | $429K-46.3% | $799K-86.6% | $6.0M+13.3% | $5.3M+201.6% | $1.7M |
| Sales and marketing | $2.2M-52.8% | $4.7M-31.4% | $6.8M | — | — |
| General and administrative | $4.0M-31.0% | $5.7M+2.7% | $5.6M+25.6% | $4.4M+82.1% | $2.4M |
| Depreciation and amortization | $889K-43.2% | $1.6M-53.6% | $3.4M | — | $803K |
| Impairment expense | $1.7M | — | — | — | — |
| Total operating expenses | $7.6M-47.2% | $14.5M-33.3% | $21.7M+36.7% | $15.9M | — |
| Loss from operation | -$4.8M+38.3% | -$7.7M+26.1% | -$10.4M-94.4% | -$5.4M-555.3% | $1.2M |
| Other income | $7K-41.7% | $12K-98.9% | $1.1M | — | — |
| Interest expense | -$1.2M-25.3% | -$968K-356.6% | -$212K+62.6% | -$567K-621.0% | -$79K |
| Loss before income tax | -$6.0M+31.1% | -$8.7M+9.4% | -$9.5M-61.1% | -$5.9M-326.9% | $2.6M |
| Provision for income tax | -$12K+65.7% | -$35K+44.4% | -$63K-162.5% | -$24K+90.7% | -$257K |
| Net loss | -$6.0M+31.3% | -$8.7M+9.6% | -$9.6M-61.5% | -$5.9M-352.8% | $2.4M |
| Deemed dividend | -$7.4M | — | — | — | — |
| Total other comprehensive loss | -$13.4M-54.3% | -$8.7M | — | — | — |
| Net loss per common share—basic (in Dollars per share) | -$1130.00+45.7% | -$2080.00+20.9% | -$2630.00-1301880.2% | -$0.20-340.5% | $0.08 |
| Net loss per common share— diluted (in Dollars per share) | -$1130.00+45.7% | -$2080.00 | — | -$0.20-340.5% | $0.08 |
| Basic (in Shares) | 5.28B+26.3% | 4.18B+14.2% | 3.66B+12334.1% | 29.4M+5.5% | 27.9M |
| Diluted (in Shares) | 5.28B+26.3% | 4.18B | — | 29.4M+5.5% | 27.9M |
Source: SEC EDGAR XBRL. % change vs prior period shown where available.
Source: SEC EDGAR 10-K and 10-Q filings. Up to 10 years annual / 16 quarters shown.